AEMD
|
Aethlon Medical, Inc.
|
US
|
NASDAQ
|
AKRO
|
Akero Therapeutics, Inc.
|
US
|
NASDAQ
|
ALGS
|
Aligos Therapeutics, Inc.
|
US
|
NASDAQ
|
BLTE
|
Belite Bio, Inc.
|
US
|
NASDAQ
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
US
|
NASDAQ
|
ETNB
|
89bio, Inc.
|
US
|
NASDAQ
|
GALT
|
Galectin Therapeutics Inc.
|
US
|
NASDAQ
|
GLS
|
Gelesis Holdings, Inc.
|
US
|
NYSE
|
GNFT
|
GENFIT S.A.
|
US
|
NASDAQ
|
IVA
|
Inventiva S.A.
|
US
|
NASDAQ
|
MTCR
|
Metacrine, Inc.
|
US
|
NASDAQ
|
PLRX
|
Pliant Therapeutics, Inc.
|
US
|
NASDAQ
|
TERN
|
Terns Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
VKTX
|
Viking Therapeutics, Inc.
|
US
|
NASDAQ
|
VRAX
|
Virax Biolabs Group Limited
|
US
|
NASDAQ
|
BIT
|
Biotron Limited
|
AU
|
ASX
|
IMC
|
Immuron Limited
|
AU
|
ASX
|
PXS
|
Pharmaxis Ltd.
|
AU
|
ASX
|
VBS
|
Vectus Biosystems Ltd
|
AU
|
ASX
|
BIOQ
|
Bioqual Inc
|
US
|
OTC
|